Tenderwize
Retour à la recherche

Non-exclusive discount agreement for dexamethasone

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2028 · 630 days left·Open·Supplies·Framework
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Dexamethason (ATC-Code: H02AB02).

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

No minimum volume or revenue guarantee; discount agreements may not lead to significant sales if pharmacists prefer oth...

Paper submission required; missing electronic submission may cause delays or errors.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Jun 27, 2028

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Provision of dexamethasone (ATC H02AB02) finished medicinal products for medical practice supply in Lower Saxony
  • Non-exclusive discount agreement under § 130a Abs. 8 SGB V
Afficher le résumé complet

This is an open-house model non-exclusive discount agreement for dexamethasone (ATC H02AB02) as part of the medical practice supply in Lower Saxony, Germany. The contracting body is AOK Niedersachsen, acting via the ARGE-SSB. The contract runs from 01.09.2026 to 31.08.2028, with the possibility to join at any time on the first of a month. No selection is performed; all qualifying pharmaceutical entrepreneurs can participate under identical terms. The tender explicitly states it is not a public procurement procedure under EU directives but is published for transparency. Electronic submission is not allowed.

Risques

No minimum volume or revenue guarantee; discount agreements may not lead to significant sales if pharmacists prefer oth...

Paper submission required; missing electronic submission may cause delays or errors.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG
  • Agreement is non-exclusive and open to all qualified market participants
  • First joining deadline: 28.07.2026 for start on 01.09.2026

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Non-exclusive discount agreement for dexamethasone

Open-house model for all pharmaceutical entrepreneurs to conclude a discount agreement for dexamethasone (ATC H02AB02) for medical practice supply in Lower Saxony. Contract duration max 24 months, earliest start 01.09.2026, latest end 31.08.2028. Joining possible on the first of each month with 35 calendar days lead time. No selection or negotiation.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Aug 2026 - Aug 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Jun 27, 2028

Détails de la procédure

Date de publication
05 Jul 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
461062-2026

Appels d'offres similaires